Phlebolymphology N°114

Treatment of vena cava obstruction and occlusion

Marzia Lugli, MD Department of Cardiovascular Surgery, Hesperia Hospital, Modena, Italy ABSTRACT Obstruction of the inferior vena cava (IVC) is a significant contributor to chronic venous insufficiency (CVI). Patients may present with a wide range of symptoms, from being asymptomatic to suffering from severely debilitating conditions. The causes of IVC obstruction can be congenital, related to malignancies, or nonmalignant. Among these, nonmalignant causes are the most common. The protocol for selecting patients for cava recanalization and stenting must be strict. The clinical basis should guide the procedural approach for inferior cava obstruction. The endovascular technique for addressing proximal deep vein…

Full text

Isolated calf deep vein thrombosis: to treat or not to treat

Andrew N. Nicolaides, MS, DSc, PhD, FRCS Vascular Screening and Diagnostic Center, Nicosia, Cyprus; and Department of Vascular Surgery, Imperial College, London, United Kingdom; and Department of Basic and Clinical Science, University of Nicosia Medical School, Nicosia, Cyprus ABSTRACT On the basis that in the presence of isolated calf deep venous thrombosis (DVT) fatal pulmonary emboli (PE) did not occur while the patient was in hospital, there was one school of thought that routine anticoagulation was unnecessary and that ultrasound surveillance would suffice, reserving anticoagulation for those in whom the thrombus extends into the popliteal or more proximal veins. However,…

Full text

Extended treatment of venous thromboembolism

Paolo Prandoni, MD, PhD Arianna Foundation on Anticoagulation, Bologna, Italy ABSTRACT After discontinuing anticoagulation, the risk of recurrent venous thromboembolism (VTE) in patients suffering an episode of unprovoked or weakly provoked VTE ranges between 30% and 50%, the rate being higher in patients with primary deep venous thrombosis (DVT). Baseline parameters that increase this risk are male sex, obesity, carriership of thrombophilia, proximal location of DVT, and renal failure. While the latest international guidelines suggest indefinite anticoagulation for most such patients, new scenarios are being offered through the availability of risk stratification models that have the potential to identify patients…

Full text

Phlebolymphology N°114 – Editorial

Dear Readers, In this new issue of Phlebolymphology, you will find the following articles: P. PRANDONI (Italy) conveys important considerations regarding the risk of recurrent venous thromboembolism (VTE) after the interruption of anticoagulation, subsequent to an unprovoked or weakly provoked episode of VTE. The author suggests a risk stratification in order to identify those patients in whom anticoagulant therapy can be safely interrupted. A. N. NICOLAIDES (Cyprus) draws attention to a frequent pathology: isolated deep venous thrombosis (DVT) of the calf. In these cases, routine anticoagulant therapy is controversial. The analysis of randomized clinical trials provides us with a clear…

Full text

Phlebolymphology N°114 (Vol 31 – N°3- 2024)

Editorial PHLEBOLOGY Extended treatment of venous thromboembolism Paolo PRANDONI (Italy) Phlebolymphology – 2024 ; 31 (3): 87 Isolated calf deep vein thrombosis: to treat or not to treat Andrew N. NICOLAIDES (Cyprus) Phlebolymphology – 2024 ; 31 (3): 94 Treatment of vena cava obstruction and occlusion Marzia LUGLI (Italy) Phlebolymphology – 2024 ; 31 (3): 100

Full text